Lenalidomide therapy in del(5)(q31)-associated myelofibrosis: cytogenetic and JAK2V617F molecular remissions (Q80220582)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460705%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Lenalidomide therapy in del(5)(q31)-associated myelofibrosis: cytogenetic and JAK2V617F molecular remissions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460705%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460705%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Tefferi A

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460705%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Lasho TL

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460705%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Mesa RA

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460705%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Pardanani A

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460705%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Hanson CA

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460705%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

26 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460705%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460705%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460705%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460705%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

1827-1828

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17460705%20AND%20SRC:MED&resulttype=core&format=json

Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404711

7 January 2021

Efficacy of lenalidomide in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404711

7 January 2021

Lenalidomide therapy in myelofibrosis with myeloid metaplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404711

7 January 2021

Hematologic and cytogenetic response to lenalidomide monotherapy in acute myeloid leukemia arising from JAK2(V617F) positive, del(5)(q13q33) myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404711

7 January 2021

Treatment of deletion 5q acute myeloid leukemia with lenalidomide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404711

7 January 2021

X-inactivation-based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a subset of JAK2V617F-negative ET and MMM patients with clonal hematopoies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404711

7 January 2021

Lenalidomide and CC-4047 inhibit the proliferation of malignant B cells while expanding normal CD34+ progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404711

7 January 2021

Lenalidomide inhibits proliferation of Namalwa CSN.70 cells and interferes with Gab1 phosphorylation and adaptor protein complex assembly

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404711

7 January 2021